Long-term remission after autologous stem-cell transplantation for relapsed histiocytic sarcoma

A. Abu-Sanad, A. Warsi, R. P. Michel, A. Nahal, G. Popradi, J.M. Storring, A.S. Liberman, T. Alcindor

Abstract


Histiocytic sarcoma is diagnosed according to established criteria. However, treatment is controversial: although lymphoma chemotherapy regimens are often used, their impact on the natural history of the disease is unclear. Here, we report a disease-free survival of 2 years after autologous stem-cell transplantation in a patient with relapsed histiocytic sarcoma.

Full Text:

PDF HTML


DOI: http://dx.doi.org/10.3747/co.19.964






Copyright © 2019 Multimed Inc.
ISSN: 1198-0052 (Print) ISSN: 1718-7729 (Online)